Omeros (OMER) Net Margin Growth (5y) (2015 - 2026)

Omeros (OMER) Net Margin Growth (5y) (2015 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn
7 Royalty Pharma 33.72 Bn 35.84 Bn -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn
10 Omeros 1.24 Bn 1.24 Bn 27.73 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 -5,180.00
Mar 31, 2026 -2,107.00
Jun 30, 2022 92,405.00
Mar 31, 2022 67,144.00
Dec 31, 2021 -26,229.00
Sep 30, 2021 41,524.00
Jun 30, 2021 42,085.00
Mar 31, 2021 121,772.00
Dec 31, 2020 -59,753.00
Sep 30, 2020 133,958.00
Jun 30, 2020 268,785.00
Mar 31, 2020 3.54 Mn
Dec 31, 2019 1.17 Mn
Sep 30, 2019 2.79 Mn
Jun 30, 2019 20.43 Mn
Mar 31, 2019 5.46 Mn
Dec 31, 2018 848,413.00
Sep 30, 2018 1.61 Mn
Jun 30, 2018 828,340.00
Mar 31, 2018 -53,889.00